ATE548366T1 - Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen - Google Patents

Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen

Info

Publication number
ATE548366T1
ATE548366T1 AT03731646T AT03731646T ATE548366T1 AT E548366 T1 ATE548366 T1 AT E548366T1 AT 03731646 T AT03731646 T AT 03731646T AT 03731646 T AT03731646 T AT 03731646T AT E548366 T1 ATE548366 T1 AT E548366T1
Authority
AT
Austria
Prior art keywords
formula
producing
dioxolane
analogo
precursors
Prior art date
Application number
AT03731646T
Other languages
English (en)
Inventor
Gregory Bydlinski
Qing Yu
Alex Cimpoia
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Application granted granted Critical
Publication of ATE548366T1 publication Critical patent/ATE548366T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03731646T 2002-01-25 2003-01-23 Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen ATE548366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35096802P 2002-01-25 2002-01-25
PCT/CA2003/000085 WO2003062229A1 (en) 2002-01-25 2003-01-23 Process for producing dioxolane nucleoside analogues

Publications (1)

Publication Number Publication Date
ATE548366T1 true ATE548366T1 (de) 2012-03-15

Family

ID=27613448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03731646T ATE548366T1 (de) 2002-01-25 2003-01-23 Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen

Country Status (7)

Country Link
US (2) US20050085638A1 (de)
EP (1) EP1467990B1 (de)
JP (1) JP4441265B2 (de)
AT (1) ATE548366T1 (de)
AU (1) AU2003236757B2 (de)
CA (1) CA2473736C (de)
WO (1) WO2003062229A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60328386D1 (de) * 2002-05-31 2009-08-27 Vidacare Corp Vorrichtung und verfahren zum erreichen von knochenmark
ES2568467T3 (es) 2004-02-03 2016-04-29 Emory University Métodos para la fabricación de nucleósidos de 1,3-dioxolano
BRPI0813036A2 (pt) * 2007-07-30 2017-10-24 Rfs Pharma Llc processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina.
CN105503838B (zh) 2015-08-26 2017-05-31 广西慧宝源医药科技有限公司 曲沙他滨的合成及其晶型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350753B1 (en) * 1988-04-11 2002-02-26 Biochem Pharma Inc. 2-Substituted-4-substituted-1,3-dioxolanes and use thereof
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
ZA923640B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9525606D0 (en) * 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
CA2505552C (en) * 2002-11-18 2012-06-05 Shire Biochem Inc. Stereoselective process for the production of dioxolane nucleoside analogues
ES2568467T3 (es) * 2004-02-03 2016-04-29 Emory University Métodos para la fabricación de nucleósidos de 1,3-dioxolano

Also Published As

Publication number Publication date
EP1467990A1 (de) 2004-10-20
CA2473736C (en) 2011-10-11
US7442813B2 (en) 2008-10-28
JP4441265B2 (ja) 2010-03-31
US20050085638A1 (en) 2005-04-21
CA2473736A1 (en) 2003-07-31
EP1467990B1 (de) 2012-03-07
WO2003062229A1 (en) 2003-07-31
US20070197784A1 (en) 2007-08-23
JP2005521660A (ja) 2005-07-21
AU2003236757B2 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
ATE374767T1 (de) Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
NZ617916A (en) Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
BRPI0506655A (pt) dehidrofenilahistinas e seus análogos, e sìntese de dehidrofenilahistinas e seus análogos
ATE353081T1 (de) Verfahren zur herstellung von duloxetin und deren verwendeten zwischenprodukten
HUP0203485A2 (hu) Purinszármazékok
ATE453645T1 (de) Verfahren zur herstellung von pyrrolotriazinverbindungen, die sich als kinaseinhibitoren eignen
ATE477238T1 (de) Verfahren zur herstellung von dithioestern
ATE262488T1 (de) Verfahren zur herstellung von silicoaluminophosphat-molekularsieben
ATE501264T1 (de) Enzymatische verfahren zur herstellung 4- substituierter 3-hydroxybuttersäure-derivate
NO20070865L (no) Fremgangsmate for fremstilling av 2'-deoksy-2',2'-difluorcytidin.
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
MX2010003887A (es) Metodo para produicir 2?-desoxi-5-azacitidina (decitabina).
ATE374760T1 (de) Verfahren zur herstellung von 4-fluor-1,3- dioxolan-2-on
ATE496056T1 (de) Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
ATE359272T1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-
ATE548366T1 (de) Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen
EE200200460A (et) Meetod tuntud tetrasooli derivaadi sünteesiks
ATE332910T1 (de) Verfahren zur herstellung von 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofura osyl)-9h-purin-6-amin
ATE286062T1 (de) Verfahren zur herstellung von l-ribavirin
ATE257832T1 (de) Verfahren zur herstellung von citalopram
ATE188215T1 (de) Stereoselektive synthese von nukleoziden analogen mit hilfe von bicyclischer zwischenverbindung
ITMI20020933A1 (it) Procedimento per la sintesi di clopidogrel
ATE496054T1 (de) Verfahren zur herstellung von 1,3-dioxolan- nucleosiden
ATE277051T1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung